UK cosmetic chain Sk:n relaunched
UK aesthetic and cosmetic surgery clinic chains Sk:n and the Harley Medical group (THMG) have been acquired and relaunched by Lorena cosmetics holdings SPV,...
DermEd Launches
Under the leadership of Dr Shobhan Manoharan, one of Australia’s most respected laser dermatologists, DermEd is setting a new standard in professional laser training....
‘The Aesthetic Edge: Cosmetic Business Booster’ launches to help transform your Aesthetic Practice
Success in aesthetic medicine requires more than just technical expertise—it demands a strategic business mindset. The Aesthetic Edge: Cosmetic Business Booster is a game-changing...
GLP-1 drugs protect brain health
A joint study by US, Chinese and German scientists has reported GLP-1 drugs – such as Wegovy and Ozempic (semaglutide) and Zepbound (tirzepatide) –...
Cholesterol changes and dementia link
A new study of 9,846 Australian and US participants, presented at the American Heart Association’s ‘Scientific Sessions 2024’, found annual changes in cholesterol levels...
Genes affect weight loss
British scientists have reported 14 ‘skinny genes’ may work together to assist weight loss. Researchers at the University of Essex, whose study was published...
Senate inquiry highlights urgent need for menopause action
Findings and recommendations from the senate inquiry into issues related to menopause and perimenopause.
On 6 November 2023, the Senate referred an inquiry into the...
Semaglutide cuts heart risks
A new meta-analysis of diabetes medications based on semaglutide – sold under brand names including Ozempic, Wegovy and Rybelsus – has confirmed a significant...
Coffee benefits gut microbiome
A new study analysing data from 77,000 people worldwide has strengthened evidence that drinking coffee may be beneficial to the gut microbiome by increasing...
Preserving muscle on GLP-1 drugs
Glucagon-like peptide-1 (GLP-1) drugs facilitate weight loss by stimulating insulin secretion, delaying emptying of the stomach contents and reducing hunger.
While the development of GLP-1...
